400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Stem Cells/Wnt / Smo / LEQ506
CAS No.: 1204975-42-7
Synonyms: NVP-LEQ506
LEQ506 is an orally bioavailable small-molecule Smoothened (Smo) antagonist with potential antineoplastic activity.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01106508 | Advanced Solid Tumors ... more >> Recurrent or Refractory Medulloblastoma Locally Advanced or Metastatic Basal Cell Carcinoma Collapse << | Phase 1 | Completed | - | United States, California ... more >> University of California at Los Angeles UCLA LeConte Location Los Angeles, California, United States, 90095 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Netherlands Novartis Investigative Site Utrecht, Netherlands, 3584CX Switzerland Novartis Investigative Site Zürich, Switzerland, 8091 United Kingdom Novartis Investigative Site Oxford, United Kingdom, OX3 7LJ Collapse << |
实验方案
技术信息
CAS号 | 1204975-42-7 | 储存条件 |
|
|
分子式 | C25H32N6O | 运输 | 蓝冰 | |
分子量 | 432.56 | 别名 | NVP-LEQ506 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01106508 | Advanced Solid Tumors ... more >> Recurrent or Refractory Medulloblastoma Locally Advanced or Metastatic Basal Cell Carcinoma Collapse << | Phase 1 | Completed | - | United States, California ... more >> University of California at Los Angeles UCLA LeConte Location Los Angeles, California, United States, 90095 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Netherlands Novartis Investigative Site Utrecht, Netherlands, 3584CX Switzerland Novartis Investigative Site Zürich, Switzerland, 8091 United Kingdom Novartis Investigative Site Oxford, United Kingdom, OX3 7LJ Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网